Endocannabinoid System Research: Cannabis & Autism Risk
Peripregnancy cannabis exposure autism risks have been linked to behavioral and developmental differences in children. Research shows varying effects depending on autism spectrum disorder symptoms. This highlights concerns about cannabis use from…
Endocannabinoid System & GLP-1 Receptor Mental Health Evidence
GLP-1 receptor agonists mental health impact has been studied using genetic analysis data. These medications may influence risk for certain psychiatric disorders, including schizophrenia. Patients and clinicians should consider the mental health…
Cannabinoid Clinical Trials: Cannabis Intervention in Teens
Sequential cannabis prevention messaging teens shows promise in clinical trials by tailoring interventions to adolescents' attitudes. This approach addresses negative reactions and delivers targeted communications. It offers a more effective strategy…
Endocannabinoid System & Maternal Cytokines: Clinical Research
Maternal immune suppression cannabis use during pregnancy is linked to changes in key cytokines. This clinical research highlights the biological effects on maternal immune function. Understanding these effects is critical for counseling pregnant…
Cannabinoid Clinical Trials: Cannabis-Induced Psychosis Risk
Clinical trials reveal that cannabis-induced psychosis risk is significant for developing schizophrenia spectrum and bipolar disorders. This risk underscores the importance of long-term psychiatric follow-up. Early monitoring after cannabis-induced…
Endocannabinoid System Research: Cannabis & HIV Smoking
Digital therapeutics tailored to people living with HIV show promising feasibility and acceptability as a scalable approach to smoking cessation. Tobacco use remains a leading driver of preventable illness and death among people with HIV, making…
Topical Cannabis Balms for AIMSS: Clinical Trial Data
Topical cannabis balms AIMSS treatment was evaluated in a randomized trial among breast cancer survivors experiencing musculoskeletal pain. The study assessed feasibility, tolerability, and preliminary efficacy of CBD and THC balms. Results provide early…
Endocannabinoid System Research: Cannabis for Autism Spectrum Disorder
Cannabis derivatives autism spectrum disorder research shows promising early signals for improving core symptoms and behavioral challenges. Current clinical trials reveal potential benefits but remain limited in size and scope. More research is needed to…
Endocannabinoid System & Teen Mental Health: Clinical Evidence
Adolescents with internalising symptoms are at increased risk for cannabis use. This study highlights the internalising pathway cannabis use adolescents face. Anxiety and depression symptoms predict cannabis initiation.
Adolescent Cannabis Use: Mental Health Risks Examined
Adolescent cannabis use and mental health clinical evidence show a significant association with increased risk of psychiatric disorders. This includes psychotic, bipolar, depressive, and anxiety disorders diagnosed in adolescence and young adulthood.…